Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Construction in Progress (2020 - 2021)

Rani Therapeutics Holdings' Construction in Progress history spans 2 years, with the latest figure at $3.5 million for Q4 2021.

  • On a quarterly basis, Construction in Progress changed 0.0% to $3.5 million in Q4 2021 year-over-year; TTM through Dec 2021 was $3.5 million, a 0.0% change, with the full-year FY2021 number at $3.5 million, changed 0.0% from a year prior.
  • Construction in Progress came in at $3.5 million for Q4 2021, roughly flat from $3.5 million in the prior quarter.
  • The five-year high for Construction in Progress was $3.5 million in Q4 2020, with the low at $3.5 million in Q4 2020.